Publications by the researcher in collaboration with Ana María Giménez Arnau (19)

2024

  1. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513

  2. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 539-546

  3. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 4, pp. 331-340

  4. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

    Contact Dermatitis

  5. Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022)

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 486-494

  6. Sodium metabisulfite a current low relevant allergen in Spain

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain

    Journal of the European Academy of Dermatology and Venereology

  2. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)

    Actas Dermo-Sifiliograficas

  3. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

    Contact Dermatitis, Vol. 88, Núm. 3, pp. 212-219

  4. [Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T479-T487

2022

  1. [Translated article] Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 3, pp. T236-T243

2021

  1. Arguments in favour of excluding MDBGN from the European baseline series. In response to “Comment on MDBGN/DBDCB, the European baseline series, and EU legislation”

    Contact Dermatitis

  2. Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 9, pp. 798-805

  3. Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Actas Dermo-Sifiliograficas

  4. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study

    Contact dermatitis, Vol. 85, Núm. 5, pp. 572-577

2020

  1. Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series

    British Journal of Dermatology

  2. Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 47-52

2019

  1. Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?

    Actas Dermo-Sifiliograficas

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82